Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gratwohl

Showing results (311-320 of 381) with videos related to

Pageof 39
Sort By:
Bone Marrow Transplantation|January 1, 1996
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT)F Frassoni, M Labopin, E Gluckman, et al.
Bone Marrow Transplantation|October 17, 2003
Differences between graft product and donor side effects following bone marrow or stem cell donationG Favre, M Beksaç, A Bacigalupo, et al.
Blood|November 14, 1997
Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow TransplantationT De Witte, A Van Biezen, J Hermans, et al.
Bone Marrow Transplantation|September 4, 2012
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centersM Stern, J R Passweg, S Meyer-Monard, et al.
Bone Marrow Transplantation|March 8, 2007
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantationA S Buser, M Stern, C Bucher, et al.
Leukemia|May 10, 2000
HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant RegistryE F Posthuma, J H Falkenburg, J F Apperley, et al.
Annals of Internal Medicine|February 27, 1999
Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working PartyA Tichelli, G Socié, M Henry-Amar, et al.
Bone Marrow Transplantation|August 31, 2004
Transmission of donor illness by stem cell transplantation: should screening be different in older donors?D Niederwieser, C Gentilini, U Hegenbart, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2010
Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMTC Koenecke, B Hertenstein, J Schetelig, et al.
Bone Marrow Transplantation|March 28, 2006
Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in SwitzerlandY Chalandon, J-M Tiercy, U Schanz, et al.
Pageof 39

Showing results (311-320 of 381) with videos related to

Sort By:
Pageof 39
Bone Marrow Transplantation|January 1, 1996
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT)F Frassoni, M Labopin, E Gluckman, et al.
Bone Marrow Transplantation|October 17, 2003
Differences between graft product and donor side effects following bone marrow or stem cell donationG Favre, M Beksaç, A Bacigalupo, et al.
Blood|November 14, 1997
Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow TransplantationT De Witte, A Van Biezen, J Hermans, et al.
Bone Marrow Transplantation|September 4, 2012
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centersM Stern, J R Passweg, S Meyer-Monard, et al.
Bone Marrow Transplantation|March 8, 2007
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantationA S Buser, M Stern, C Bucher, et al.
Leukemia|May 10, 2000
HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant RegistryE F Posthuma, J H Falkenburg, J F Apperley, et al.
Annals of Internal Medicine|February 27, 1999
Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working PartyA Tichelli, G Socié, M Henry-Amar, et al.
Bone Marrow Transplantation|August 31, 2004
Transmission of donor illness by stem cell transplantation: should screening be different in older donors?D Niederwieser, C Gentilini, U Hegenbart, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2010
Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMTC Koenecke, B Hertenstein, J Schetelig, et al.
Bone Marrow Transplantation|March 28, 2006
Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in SwitzerlandY Chalandon, J-M Tiercy, U Schanz, et al.
Pageof 39